Clinical Trials Logo

Clinical Trial Summary

The purpose of the study is to define the economic value of implantable cardioverter defibrillator (ICD) remote monitoring for hospitals, third payers and patients in Italy. Aims of the study are to develop a hospital cost minimization analysis and a cost effectiveness analysis based on direct estimation of costs and quality of life deriving from remote follow-up (performed with Merlin@home and Merlin.net) compared to standard follow-up in the management of ICD implanted patients.


Clinical Trial Description

TARIFF is a prospective observational study aimed to measure direct, indirect costs and quality of life of all participants for the duration of the observational timeframe. Purpose of cost collecting is to include a complete set of medical services and productivity loses that could be directly affected by the different clinical Follow-Up (FU) pathway. The study consists of 2 phases: firstly standard follow up costs will be collected for 100 pts, then all costs associated to remote follow ups will be collected for other 100 patients. ;


Study Design


Related Conditions & MeSH terms

  • Complication of Cardiac Defibrillator

NCT number NCT01075516
Study type Observational
Source Abbott Medical Devices
Contact
Status Completed
Phase
Start date December 2009
Completion date April 2013

See also
  Status Clinical Trial Phase
Recruiting NCT02331511 - Prevention of Venous Obstruction After Implantation of Cardiac Pacemaker and Defibrillator N/A